217 related articles for article (PubMed ID: 24209900)
21. [Methylene blue in ifosfamide-induced encephalopathy].
Koschuth A; Späth-Schwalbe PE; Possinger K
Dtsch Med Wochenschr; 1996 Sep; 121(39):1210. PubMed ID: 8925751
[No Abstract] [Full Text] [Related]
22. [Incidence and risk factors for ifosfamide-related encephalopathy in sarcoma patients].
Stern N; Sakji I; Defachelles AS; Lervat C; Ryckewaert T; Marliot G; Peugniez C; Deplanque D; Penel N
Bull Cancer; 2017 Mar; 104(3):208-212. PubMed ID: 27986268
[TBL] [Abstract][Full Text] [Related]
23. Ifosfamide causes a diazepam-sensitive encephalopathy.
Simonian NA; Gilliam FG; Chiappa KH
Neurology; 1993 Dec; 43(12):2700-2. PubMed ID: 8255482
[TBL] [Abstract][Full Text] [Related]
24. Generalized periodic epileptiform discharges in critically ill children: a continuum of status epilepticus or an epiphenomenon?
Akman CI; Riviello JJ
J Clin Neurophysiol; 2011 Aug; 28(4):366-72. PubMed ID: 21811125
[TBL] [Abstract][Full Text] [Related]
25. Role of thiamine in managing ifosfamide-induced encephalopathy.
Hamadani M; Awan F
J Oncol Pharm Pract; 2006 Dec; 12(4):237-9. PubMed ID: 17156595
[TBL] [Abstract][Full Text] [Related]
26. Nonconvulsive status epilepticus in children: clinical and EEG characteristics.
Tay SK; Hirsch LJ; Leary L; Jette N; Wittman J; Akman CI
Epilepsia; 2006 Sep; 47(9):1504-9. PubMed ID: 16981867
[TBL] [Abstract][Full Text] [Related]
27. Ifosfamide neurotoxicty in a young female with a remarkable response to thiamine.
Imtiaz S; Muzaffar N
J Pak Med Assoc; 2010 Oct; 60(10):867-9. PubMed ID: 21381624
[TBL] [Abstract][Full Text] [Related]
28. Adverse event profiles of ifosfamide-induced encephalopathy analyzed using the Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases.
Shimada K; Hasegawa S; Nakao S; Mukai R; Matsumoto K; Tanaka M; Uranishi H; Masuta M; Nishida S; Shimizu S; Hayashi Y; Suzuki A; Nakamura M
Cancer Chemother Pharmacol; 2019 Nov; 84(5):1097-1105. PubMed ID: 31502115
[TBL] [Abstract][Full Text] [Related]
29. Ifosfamide-induced encephalopathy in patients with uterine sarcoma.
Liu YL; Tsai SH; Chang FW; Yu MH
Taiwan J Obstet Gynecol; 2010 Mar; 49(1):77-80. PubMed ID: 20466298
[TBL] [Abstract][Full Text] [Related]
30. [Ifosfamide-related encephalopathy. Report of two cases].
Dourthe LM; Coutant G; Desrame J; Merrer J; Daly JP
Rev Med Interne; 1999 Mar; 20(3):264-6. PubMed ID: 10216884
[TBL] [Abstract][Full Text] [Related]
31. Ifosfamide induced encephalopathy in a child with osteosarcoma.
Sarbay H; Demir ÜF; Yılmaz G; Atay AA; Malbora B
J Oncol Pharm Pract; 2021 Jul; 27(5):1302-1306. PubMed ID: 33023384
[TBL] [Abstract][Full Text] [Related]
32. EEG patterns and imaging correlations in encephalopathy: encephalopathy part II.
Kaplan PW; Rossetti AO
J Clin Neurophysiol; 2011 Jun; 28(3):233-51. PubMed ID: 21633250
[TBL] [Abstract][Full Text] [Related]
33. Ifosfamide-related encephalopathy in elderly patients : report of five cases and review of the literature.
Brunello A; Basso U; Rossi E; Stefani M; Ghiotto C; Marino D; Crivellari G; Monfardini S
Drugs Aging; 2007; 24(11):967-73. PubMed ID: 17953463
[TBL] [Abstract][Full Text] [Related]
34. Ifosfamide-induced nonconvulsive status epilepticus.
Bhardwaj A; Badesha PS
Ann Pharmacother; 1995 Dec; 29(12):1237-9. PubMed ID: 8672829
[TBL] [Abstract][Full Text] [Related]
35. Electroencephalographic changes in pyridoxine-dependant epilepsy: new observations.
Naasan G; Yabroudi M; Rahi A; Mikati MA
Epileptic Disord; 2009 Dec; 11(4):293-300. PubMed ID: 20031502
[TBL] [Abstract][Full Text] [Related]
36. Ifosfamide-induced encephalopathy and movement disorder.
Ames B; Lewis LD; Chaffee S; Kim J; Morse R
Pediatr Blood Cancer; 2010 Apr; 54(4):624-6. PubMed ID: 19953647
[TBL] [Abstract][Full Text] [Related]
37. On the origin of EEG-slowing and encephalopathy during induction treatment of acute lymphoblastic leukemia.
Korinthenberg R; Scheuring B; Boos J; Niemeyer C
Med Pediatr Oncol; 2002 Dec; 39(6):566-72. PubMed ID: 12376979
[TBL] [Abstract][Full Text] [Related]
38. Pearls, perils, and pitfalls in the use of the electroencephalogram.
Markand ON
Semin Neurol; 2003 Mar; 23(1):7-46. PubMed ID: 12870104
[TBL] [Abstract][Full Text] [Related]
39. Cephalosporin-related neurotoxicity: Metabolic encephalopathy or non-convulsive status epilepticus?
Triplett JD; Lawn ND; Chan J; Dunne JW
J Clin Neurosci; 2019 Sep; 67():163-166. PubMed ID: 31201049
[TBL] [Abstract][Full Text] [Related]
40. Hydration, methylene blue, and thiamine as a prevention regimen for ifosfamide-induced encephalopathy.
Gharaibeh EZ; Telfah M; Powers BC; Salacz ME
J Oncol Pharm Pract; 2019 Oct; 25(7):1784-1786. PubMed ID: 30348070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
